Cargando…

Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma

BACKGROUND: The aim of this study was to compare radiotherapy plans for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL) using helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), Fixed-Field intensity-modulated radiotherapy (IMRT), and three-dimensional conformal radiotherapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xianfeng, Huang, Erliang, Wang, Ying, He, Yanan, Luo, Huanli, Zhong, Mingsong, Qiu, Da, Li, Chao, Yang, Han, He, Guanglei, Zhou, Juan, Jin, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408431/
https://www.ncbi.nlm.nih.gov/pubmed/28449713
http://dx.doi.org/10.1186/s13014-017-0812-1
_version_ 1783232306129928192
author Liu, Xianfeng
Huang, Erliang
Wang, Ying
He, Yanan
Luo, Huanli
Zhong, Mingsong
Qiu, Da
Li, Chao
Yang, Han
He, Guanglei
Zhou, Juan
Jin, Fu
author_facet Liu, Xianfeng
Huang, Erliang
Wang, Ying
He, Yanan
Luo, Huanli
Zhong, Mingsong
Qiu, Da
Li, Chao
Yang, Han
He, Guanglei
Zhou, Juan
Jin, Fu
author_sort Liu, Xianfeng
collection PubMed
description BACKGROUND: The aim of this study was to compare radiotherapy plans for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL) using helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), Fixed-Field intensity-modulated radiotherapy (IMRT), and three-dimensional conformal radiotherapy (3D-CRT). METHODS: Eight patents with Stage I-II NNKTL treated with IMRT were re-planned for HT, VMAT (two full arcs), and 3D-CRT. The quality of target coverage, the exposure of normal tissue and the efficiency of radiation delivery were analyzed. RESULTS: HT showed significant improvement over IMRT in terms of D(98%), cold spot volume and homogeneity index (HI) of planning target volume (PTV). VMAT provided best dose uniformity (p = 0.000) to PTV, while HT had best dose homogeneity among the four radiotherapy techniques (p = 0.000) to PTV. VMAT obviously reduced treatment time (p = 0.010; 0.000) compared to HT and IMRT. Mean dose of left and right optic nerve was significantly reduced by IMRT compared to HT (19.86%, p = 0.000; 21.40%, p = 0.002) and VMAT (8.97%, p = 0.002; 9.35%, p = 0.001), and maximum dose of left lens of VMAT increased over the HT (36.25%, p = 0.043) and IMRT (40.65%, p = 0.001). CONCLUSION: The unexpected results show that both HT and VMAT can achieve higher conformal treatment plans while getting worse organs at risk (OARs) sparing than IMRT for patients with Stage I-II NNKTL. VMAT requires the shortest delivery time, and IMRT delivers the lowest dose to most OARs. The results could provide guidance for selecting proper radiation technologies for different cases.
format Online
Article
Text
id pubmed-5408431
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54084312017-05-02 Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma Liu, Xianfeng Huang, Erliang Wang, Ying He, Yanan Luo, Huanli Zhong, Mingsong Qiu, Da Li, Chao Yang, Han He, Guanglei Zhou, Juan Jin, Fu Radiat Oncol Research BACKGROUND: The aim of this study was to compare radiotherapy plans for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL) using helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), Fixed-Field intensity-modulated radiotherapy (IMRT), and three-dimensional conformal radiotherapy (3D-CRT). METHODS: Eight patents with Stage I-II NNKTL treated with IMRT were re-planned for HT, VMAT (two full arcs), and 3D-CRT. The quality of target coverage, the exposure of normal tissue and the efficiency of radiation delivery were analyzed. RESULTS: HT showed significant improvement over IMRT in terms of D(98%), cold spot volume and homogeneity index (HI) of planning target volume (PTV). VMAT provided best dose uniformity (p = 0.000) to PTV, while HT had best dose homogeneity among the four radiotherapy techniques (p = 0.000) to PTV. VMAT obviously reduced treatment time (p = 0.010; 0.000) compared to HT and IMRT. Mean dose of left and right optic nerve was significantly reduced by IMRT compared to HT (19.86%, p = 0.000; 21.40%, p = 0.002) and VMAT (8.97%, p = 0.002; 9.35%, p = 0.001), and maximum dose of left lens of VMAT increased over the HT (36.25%, p = 0.043) and IMRT (40.65%, p = 0.001). CONCLUSION: The unexpected results show that both HT and VMAT can achieve higher conformal treatment plans while getting worse organs at risk (OARs) sparing than IMRT for patients with Stage I-II NNKTL. VMAT requires the shortest delivery time, and IMRT delivers the lowest dose to most OARs. The results could provide guidance for selecting proper radiation technologies for different cases. BioMed Central 2017-04-27 /pmc/articles/PMC5408431/ /pubmed/28449713 http://dx.doi.org/10.1186/s13014-017-0812-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Xianfeng
Huang, Erliang
Wang, Ying
He, Yanan
Luo, Huanli
Zhong, Mingsong
Qiu, Da
Li, Chao
Yang, Han
He, Guanglei
Zhou, Juan
Jin, Fu
Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
title Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
title_full Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
title_fullStr Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
title_full_unstemmed Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
title_short Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
title_sort dosimetric comparison of helical tomotherapy, vmat, fixed-field imrt and 3d-conformal radiotherapy for stage i-ii nasal natural killer t-cell lymphoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408431/
https://www.ncbi.nlm.nih.gov/pubmed/28449713
http://dx.doi.org/10.1186/s13014-017-0812-1
work_keys_str_mv AT liuxianfeng dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT huangerliang dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT wangying dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT heyanan dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT luohuanli dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT zhongmingsong dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT qiuda dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT lichao dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT yanghan dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT heguanglei dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT zhoujuan dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma
AT jinfu dosimetriccomparisonofhelicaltomotherapyvmatfixedfieldimrtand3dconformalradiotherapyforstageiiinasalnaturalkillertcelllymphoma